Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

MLA

Lodewyk F. A. Wessels, et al. “Genomic Patterns Resembling BRCA1- and BRCA2-Mutated Breast Cancers Predict Benefit of Intensified Carboplatin-Based Chemotherapy.” Breast Cancer Research, vol. 16, no. 3, May 2014. EBSCOhost, https://doi.org/10.1186/bcr3655.

APA

Lodewyk F. A. Wessels, Jos Jonkers, Michael Hauptmann, Sabine C. Linn, Elisabeth G.E. de Vries, Petra M. Nederlof, Esther H. Lips, Jelle Wesseling, Marieke A. Vollebergh, Marc J. vd Vijver, Harm van Tinteren, & Sjoerd Rodenhuis. (2014). Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy. Breast Cancer Research, 16(3). https://doi.org/10.1186/bcr3655

Chicago

Lodewyk F. A. Wessels, Jos Jonkers, Michael Hauptmann, Sabine C. Linn, Elisabeth G.E. de Vries, Petra M. Nederlof, Esther H. Lips, et al. 2014. “Genomic Patterns Resembling BRCA1- and BRCA2-Mutated Breast Cancers Predict Benefit of Intensified Carboplatin-Based Chemotherapy.” Breast Cancer Research 16 (3). doi:10.1186/bcr3655.